drugset / Trial / NCT04403971

0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia

NCT04403971

RandomizedSequentialTriple-blindPrevention

Summary

Chlorhexidine is a effective strategy in reducing ventilator associated pneumonia. However, it is unclear if prophylactic 0.12% chlorhexidine oral rinse can reduce the risk of non-ventilator hospital-acquired pneumonia among hospitalized patients.

Timeline

Start
2020-05-25
Primary completion
2020-10-31
Completion
2020-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule 10 ml Oral
Comparator Essential oils Unknown 10 ml Oral

Indications